China VC Weekly: Biotech, Open-source and New Hefty Funds

Nov 23, 2020

∙ Paid

Last week saw two prominent Chinese VC funds – Future Capital and Qiming Venture Partners – raise new US dollar funds. In other news, biotech firm D3 Bio bagged $200 million to expand its product portfolio, while open-source software developer Zilliz closed an investment round of $43 million.

Biotech Startup D3 Bio Raises $200 Million in Series A round

D3…

Keep reading with a 7-day free trial

Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.